Denosumab vs Zoledronate After Vertebroplasty

Osteoporotic vertebral compression fracture (OVCF) patients had a proportion of secondary fractures after percutaneous vertebroplasty (PVP). Denosumab and zoledronate acid is both effective to prevent...

Lead sponsor: Shenzhen People's Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

UNKNOWNNA

Denosumab vs Alendronate After Vertebroplasty

NCT05662358 · Denosumab Allergy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 18, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment75

Start dateJan 2021

Last updatedJan 18, 2023

Condition

Denosumab Allergy Zoledronic Acid Allergy

Locations shown

ShenzhenPH

Shenzhen, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 18, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions